EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast

Alice Kamau iD, Moses Musau, Stella Mwakio, David Amadi, Amek Nyaguara, Philip Bejon, Anna C Seale, James A Berkley, Robert W Snow

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e875-e883

DOI: 10.1093/cid/ciac509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 22.06.2022. Verfasst von Alice Kamau und 8 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Research, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Pregnancy Complications, Pregnancy Complications, Parasitic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, DFID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intermittent preventive treatment (IPTp) for pregnant women with sulfadoxine–pyrimethamine (SP) is widely implemented for the prevention of malaria in pregnancy and adverse birth outcomes. The efficacy of SP is declining, and there are concerns that IPTp may have reduced impact in areas of high resistance. We sought to determine the protection afforded by SP as part of IPTp against adverse birth outcomes in an area with high levels of SP resistance on the Kenyan coast.

Methods

A secondary analysis of surveillance data on deliveries at the Kilifi County Hospital between 2015 and 2021 was undertaken in an area of low malaria transmission and high parasite mutations associated with SP resistance. A multivariable logistic regression model was developed to estimate the effect of SP doses on the risk of low birthweight (LBW) deliveries and stillbirths.

Results

Among 27 786 deliveries, 3 or more doses of IPTp-SP were associated with a 27% reduction in the risk of LBW (adjusted odds ratio [aOR], 0.73; 95% confidence interval [CI], .64–.83; P < .001) compared with no dose. A dose-response association was observed with increasing doses of SP from the second trimester linked to increasing protection against LBW deliveries. Three or more doses of IPTp-SP were also associated with a 21% reduction in stillbirth deliveries (aOR, 0.79; 95% CI, .65–.97; P = .044) compared with women who did not take any dose of IPTp-SP.

Conclusions

The continued significant association of SP on LBW deliveries suggests that the intervention may have a non-malaria impact on pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaPregnancy ComplicationsPregnancy Complications, ParasiticFemalePregnancyHumansKenyaPyrimethamineSulfadoxineDrug CombinationsPregnancy OutcomeStillbirth

Stichwörter der Autor:innen

IPTp-SPKenyaSP resistancelow birthweightstillbirths

Substanzen

AntimalarialsPyrimethamineSulfadoxineDrug Combinations

Autor:innen und Institutionen

  • Public Health Research, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.
  • Epidemiology and Demography, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom.

ORCID-Profile: Alice Kamau

Förderung

  • Wellcome Trust
  • Medical Research Council
  • DFID
  • Global Health
  • Bill and Melinda Gates Foundation

Zitieren

APA

Kamau, A., Musau, M., Mwakio, S., Amadi, D., Nyaguara, A., Bejon, P., Seale, A. C., Berkley, J. A., & Snow, R. W. (2023). Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast. Clinical Infectious Diseases, 76(3), e875-e883. https://doi.org/10.1093/cid/ciac509

Vancouver

Kamau A, Musau M, Mwakio S, Amadi D, Nyaguara A, Bejon P, et al. Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast. Clinical Infectious Diseases. 2023;76(3):e875-e883. doi:10.1093/cid/ciac509

BibTeX
@article{Kamau2023,
  author = {Kamau, Alice and Musau, Moses and Mwakio, Stella and Amadi, David and Nyaguara, Amek and Bejon, Philip and Seale, Anna C and Berkley, James A and Snow, Robert W},
  title = {Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e875--e883},
  doi = {10.1093/cid/ciac509}
}
Kostenlos starten →